Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

208.40B

Market cap208.40B

Price-Earnings ratio

11.16

Price-Earnings ratio11.16

Dividend yield

2.69%

Dividend yield2.69%

Average volume

12.28M

Average volume12.28M

High today

$47.19

High today$47.19

Low today

$45.60

Low today$45.60

Open price

$45.98

Open price$45.98

Volume

19.50M

Volume19.50M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

TipRanks 6h

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

24/7 Wall St. 7h

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? By Vandita Jadeja Published Aug 19, 12:00PM EDT Quick Read LLY dominates the GLP-1 race with 48% revenue...

TipRanks 9h

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

Novo Nordisk (NVO) is testing lower doses of oral Wegovy to identify the minimum effective dose, a move that could improve tolerability, accessibility, and econ...

Analyst ratings

58%

of 36 ratings

Buy

33.3%

Hold

58.3%

Sell

8.3%

More NVO News

24/7 Wall St. 9h

Stock Forecast: The Market is Sleeping on Eli Lilly's Next $1 Trillion Opportunity

Stock Forecast: The Market is Sleeping on Eli Lilly’s Next $1 Trillion Opportunity By Vandita Jadeja Published Aug 19, 9:30AM EDT Quick Read LLY earns a BUY a...

The Wall Street Journal 10h

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

The lowest current starter dose of Wegovy available is 1.5 milligrams. Hannah Beier / Reuters Novo Nordisk NOVO.B -0.51 %decrease; down pointing triangle is st...

TipRanks 12h

United Laboratories Warns of Sharp First-Half Profit Decline

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Seeking Alpha 14h

Novo Nordisk tests low-dose Wegovy pill in new study

Novo Nordisk (NVO) is testing lower doses of its Wegovy obesity pill in a new study aimed at determining how low patients can go in their dose while still achie...

TipRanks 1d

Novo Nordisk Tests Semaglutide’s Alzheimer’s Potential: What Investors Should Watch

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

TipRanks 2d

Novo Nordisk Expands Treasury Stock as 2026 Share Buyback Passes DKK 8 Billion

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 2d

Novo Nordisk Lawsuit Ruling Lets Some Securities Claims Move Forward

A federal judge in New Jersey has allowed part of an investor securities lawsuit against Novo Nordisk A/S (NVO) to proceed, while dismissing most of the challen...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.